Market Place
Sourcing Support
All News #Library
Biotech
Asahi Kasei Launches PhI Trial for Peptide in Autoimmune Diseases
20 Apr 2026 //
PHARMIWEB
PeptiDream, Alnylam Reach Milestone In Targeted Sirna Delivery
18 Dec 2025 //
BUSINESSWIRE
PeptiDream Announces Oral Dual IL-17A/F Inhibitor Results
17 Dec 2025 //
BUSINESSWIRE
Curium, PeptiDream Start 64Cu-PSMA-I&T Prostate Cancer Trial
15 Oct 2025 //
GLOBENEWSWIRE
PeptiDream Advances Peptide Therapy for Gastric Cancer Claudin 18.2
12 Dec 2024 //
BUSINESSWIRE
PeptiDream Shows Oral Myostatin Inhibitors Prevent Lean Mass Loss
12 Dec 2024 //
BUSINESSWIRE
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
30 Apr 2024 //
BUSINESSWIRE
Novartis pays PeptiDream $180M as radiopharma big bang continues
29 Apr 2024 //
FIERCE BIOTECH
PeptiDream Announces Collaboration and License Agreement with Genentech
20 Sep 2023 //
BUSINESSWIRE
PeptiDream Announces Nomination of Second Peptide Radiopharmaceutical Therapeutic Development Candidate
22 Mar 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.